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Objectives. The objective of this one-group, repeated-measures design was to explore the acceptance of auricular point acupressure
(APA) to reduce chronic low back pain (CLBP) and estimate minimum clinically important diﬀerences (MCIDs) for pain intensity
change. Methods. Subjects received 7-day APA treatment. After appropriate acupoints were identified, vaccaria seeds were carefully
taped onto each selected auricular point for 7-day. The Brief Pain Inventory Short Form (BPI) was used to collect outcome data.
Results. A total of 74 subjects participated in the study. Ten subjects dropped out and the retention rate was 87%. Subjects reported
a 46% reduction in BPI worst pain, and over 50% reduction in BPI average pain, overall pain severity and pain interference by
the end of study, and 62.5% subjects also reported less pain medication use. The MCIDs for the subscale of BPI ranged from .70
to 1.86 points. The percentage improvement of MCIDs from baseline was between 14.5–24.9%. Discussion. APA appears to be
highly acceptable to patients with CLBP. A sham group is needed in order to diﬀerentiate the true eﬀects of APA from the possible
psychological eﬀects of more frequent visits by the auricular therapist and patients’ expectation of the APA treatment.
1. Introduction
Chronic low back pain (CLBP) imposes a significant societal
and economic burden on the United States. The prevalence
of CLBP has increased from 3.9% in 1992 to 10.2% of
the population in the United States in 2006 [1], with an
estimated annual cost of $84.1 billion for direct treatment
and an additional $624.8 billion as a result of loss of
productivity [2, 3]. Despite the availability of more than
200 treatment options for CLBP [4], improvements in
patient outcome are limited [5]. Acupuncture oﬀers another
treatment option for CLBP and has shown promising eﬀects,
namely, short-term pain relief [6, 7]. However, conflicts
exist about the eﬀectiveness between acupuncture alone and
conventional therapies [8]. The widespread application of
acupuncture to manage CLBP is limited by the need for
patients to travel to the acupuncture site [9], fear of needles,
and the cost of acupuncture treatment not typically being
covered by insurance [10].
Auricular therapy, an adjunct to acupuncture, is based
on the same ancient Traditional Chinese Medicine (TCM)
as acupuncture and uses acupoints on specific areas of
the inner and outer ear lobe to treat disease/illness [11,
12]. In TCM, a disease is considered to be caused by the
imbalance of a person’s energy, Qi [11]. The stimulation of
auricular acupoints regulates Qi, activates the meridians and
collateral systems, and has been successful in treating health
problems [11, 12]. In the 1950s, a French neurosurgeon, Dr.
Paul Nogier, theorized that the ear represents the inverted
fetus within the womb, and proposed the somatotopic
correspondence of specific parts of the body to specific
parts of the ear [11, 12]; the current auricular therapy
practiced worldwide is based on Nogier’s theory. The World
Health Organization considers auricular medicine a form
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of microacupuncture that can aﬀect the whole body [13].
Although popular in Asia for over 2000 years and in Europe
for the past 60, auricular therapy has not yet been widely
practiced by health care providers in the United States.
The most common auricular therapies include acupunc-
ture, electroacupuncture stimulation, and acupressure. Stud-
ies using auricular therapy (acupuncture or acupressure
on the external ear) have shown promising eﬀects in pain
management. A recent meta-analysis of auricular therapy for
pain management (17 studies: 8 perioperative, 4 acute, and 5
chronic pain), found auricular therapy reduced analgesic use
for perioperative pain (standard mean diﬀerence (SMD) =
0.54 [95% confidence interval (CI) 0.30, 0.77]), and reduced
pain intensity for acute and chronic pain (SMD = 1.56
[95% (CI): 0.85, 2.26]) than for controls [14]; three of
the studies were conducted in the USA [15–17]. Electrical
stimulation of auricular points treatment has been found to
be more eﬀective than manual stimulation [18, 19]. When
the auricular acupuncture was combined with exercise, the
benefits for CLBP were increased even more [20, 21]. The
needle of auricular acupuncture can stay in situ for up to
1 week and therefore reduce the number of therapist oﬃce
visits. While these findings support the growing enthusiasm
for this complementary and alternative approach to pain
management, the authors note several limitations, including
limited evidence from rigorous clinical trials, small sample
sizes, and inadequate blinding procedures [22]. In addition,
the practice of auricular acupuncture needs to be performed
by licensed acupuncturists.
Auricular Point Acupressure (APA) [11, 12] is a less fre-
quently employed yet validated method to deliver auricular
therapy, which utilizes very tiny botanical plant seeds (e.g.,
approximately 2mm size) taped onto the patient’s ear for
acupoint stimulation. Once applied by a qualified therapist,
the taped seeds remain in place for up to 1–3 weeks, depend-
ing on the subject’s skin condition. The patient is instructed
to apply pressure to the taped seed when experiencing pain.
In addition, the selection of auricular acupoints for the APA
treatment is individualized according to the corresponding
body part exhibiting symptoms. In general, acupressure is
less eﬀective at the same duration, but acupressure can obtain
the same benefits as acupuncture when it is applied for a
longer time [23, 24]. APA is also adaptable to health care
professional practice because it can be taught along the
continuum of health professional education, which would
enable more health care professionals to incorporate it into
practice to provide pain relief and augment the eﬀects of pain
medication.
In order to interpret the APA eﬀects of pain intensity
change (patient-reported measure) appropriately, minimum
clinical important diﬀerences (MCIDs) have been suggested
[25]. MCIDs represent the smallest change considered by
the patient as an improvement. MCIDs may be estimated
using anchor-based or distribution-based methods [26].
Anchor-based methods are based on the comparison of
patient-rated outcomes to an anchor, that is, the patient’s
global impression of improvement [27]. Distribution-based
methods use standard error measurement (SEM), standard
deviations, and eﬀect size [28, 29]. The use of MCIDs
facilitates our ability to determine even small improvements
in pain scores for this feasibility study. Thus, this study
was designed to explore the acceptance of APA to reduce
CLBP, assess subject adherence, assess safety/tolerability
(i.e., somatic symptoms), and estimate minimum clinically
important diﬀerences for pain intensity change.
2. Methods
This study employed a repeated-measures observational
design, and subjects received a 7-day auricular point acu-
pressure (APA) research protocol for the assessment and
management of CLBP. Data (pain severity, pain interference,
and medication use) were collected at baseline, daily for 7
days (total 8 time points).
2.1. Subjects and Setting. Subjects with CLBP independently
approached the PI with requests to participate in the study
whenDr. Yehwas recruiting subjects with cancer-related pain
from the UPMC (University of Pittsburgh, Medical Center)
Cancer Center follow-up clinic in McKeesport (a suburb of
Pittsburgh, 10 miles from the main campus). Those subjects
were friends and family of participants in the cancer pain
study. Thus, the IRB was revised to expand the study to
recruit subjects with CLBP. Subjects were eligible for this
study if they were 18 years of age or above, had nonspecific
low back pain for more than 6 months, pain intensity ≥ 3 on
a 10 point numerical pain scale at the time of recruitment,
had no surgery in previous 3 months, had not received any
acupuncture or acupressure treatments in the previous three
months, and were able to read and write English.
2.2. Measures. We used the Brief Pain Inventory (BPI) [30]
to assess the severity and impact of pain on daily functions in
the previous 24 hours. Included were front and back body
diagrams, pain intensity rating (4 items: worst pain, least
pain, average pain, and current) and pain interferences (7
items) using 0–10 scales, as well as pain medication used
and the percentage of pain relief by pain medication. Two
singular items of worst pain, average pain, a composite of the
4 items of pain severity and pain interference were used as
the outcome variables. Higher scores indicated that patients
had higher pain intensity. For data analysis, the score for each
outcome variable was standardized so that each outcome
variable had potential score of 0–10.
Analgesic use was monitored on the subject’s diary and
the BPI. The Medication Quantification Score Version III
(MQS) [31] was used to compute a single numeric value for
a subject’s pain medication profile. This score was based on
the subject’s use of drug by class, dose, and detriment (risk).
The decreased MSQ III score was associated with improved
outcome (less pain intensity) [31]. The classification of
the drug class followed the suggestion of World Health
Organization (WHO) level 1–3 analgesic drugs, coanalgesic
drugs (tricyclic antidepressants, antiepileptics), and other
drugs such as benzodiazepines or muscle relaxants.
The Perceived Therapeutic Eﬃcacy Scale was adminis-
tered to examine subjects’ expectations regarding the benefit
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of acupressure. This scale was adapted from the Perceived
Treatment Eﬃcacy Assessment in Rheumatoid Arthritis scale
[32].
The subjects’ satisfaction with the treatment and the
extent to which they perceived the treatment to be a burden
was assessed with a modified version of the Satisfaction
Questionnaire used by a previous study [33]. Subjects were
interviewed by phone at the end of the study regarding
their subjective experiences during the APA intervention and
were called daily to assess their pain intensity, stimulation
times (frequency), and stimulation duration for acupoints.
One item of the patient-rated 5-category ordinal assessment
measures the patient’s general pain improvement and was
scored as (1) much better, (2) better, (3) about the same, (4)
worse, and (5) much worse.
2.3. Auricular Point Acupressure Treatment Protocol. The
auricular points selected for pain treatment included two
commonly used acupoints (Shenmen and nervous subcor-
tex) as well as the acupoints corresponding to where patients
had pain, including the lumber vertebral area near the
antihelix middle line and the upper 4/5 positive area (front
and back ear area) (see Figure 1). The Shenmen point has
been recognized as having wide application for pain [34], and
the nervous subcortex point is related to vasodilation in the
holistic nature of the therapy [11]. The number of acupoints
and the locations on the ears for each patient may be diﬀerent
because each patient may have had diﬀerent locations of
pain and the pain is projected onto the ear according to
somatic topography. The selection of corresponding points
was made according to Dr. Huang’s ear reflex theory [35,
36] and personal communication with Dr. Huang (Nov
27, 2010). Dr. Huang, who received the Recognition of
Mastery and Lifetime Achievement Award at the World
International Symposium on Auricular Therapy & Auricular
Medicine (2002), is regarded as the “Mother of Auricular
Therapy” in China and is the President of AuricularMedicine
International Research & Training Center, Florida [11]. Dr.
Yeh, the first author of this study, studies with Dr. Huang and
is a certified auricular therapist.
Acupoints on each subject were identified using an
electronic acupoint locator. The acupoint locator (Figure 2)
was connected to two probes: one was held by the subject
and the other was used by the PI to locate the acupoints.
The acupoint was identified when the locator made a sound
indicating the corresponding location on the body. Vaccaria
seeds (Figure 3) were carefully taped onto each selected
auricular point. We demonstrated the pressing technique
to subjects before asking them to do a reciprocal demon-
stration. Moderate stimulation was used for the therapy.
Subjects were told that they should press the seed-tapes with
increasing pressure until they felt either slight discomfort or
a tingling sensation. Subjects were asked to press each of their
taped acupoints at least 3 times a day for at least 3 minutes
for each of the seven days of the study even if they did not
have symptoms. They were also instructed to press the seed-
tapes whenever they experienced pain. Tapes were kept on
auricular points for 7 days, and patients were asked to remove
them on day eight.
2.4. Procedure. After the consent form was signed by the
subjects, subjects received the treatment by Dr. Yeh. A data
collector, who was not Dr. Yeh, called the subjects daily
to remind the subjects to perform APA intervention (i.e.,
frequency and duration) at home, document any side eﬀects
of APA, and collect the outcome measures (BPI short form
and medication use) for the past 24 hours. All of the data
were entered by this trained data collector.
3. Data Analysis
Descriptive statistics were used to examine the demographic
characteristics of all (n = 64) participants. We used the
generalized additive model [37] to accomplish a longitudinal
data analysis for evaluating the APA intervention on the
pain outcomes (severity and interference) before and daily
for 7 days of assessment. Four continuous measurements
(worst pain, average pain, overall pain severity, and pain
interference) were investigated.
In order to estimate minimum clinically important
diﬀerences (MCIDs) for the BPI average pain, worst pain,
and severity score (the mean of the BPI pain scale values:
right now, average, least, and worst), the treatment sat-
isfaction measure of “subject’s overall impression of pain
improvement” was used as an anchor. Pain improvement is
a patient-rated 5-category ordinal assessment that measures
the patient’s general level of improvement and is coded as
follows: (1) (much better), (2) (better), (3) (about the same),
(4) (worse), and (5) (much worse). End point scores of (1)
(much better) and (2) (better) were used to identify patients
who had an overall clinically important diﬀerence, also called
“minimal clinically relevant improved,” whereas the “stable”
group was the subjects who rated their pain improvement
as (3) (about the same). The MCID was calculated as the
diﬀerence in the unadjusted mean change in the BPI scores
between the “stable” group and “improved” group. In final
analysis ofMCIDs, only subjects who had complete data were
used (n = 36 for Improved group and = 22 for Stable group,
6 subjects were not included due to missing data). MCIDs
were also expressed as a percentage reduction from the mean
baseline scores for the stable and improved groups of each
measure. All data analysis was performed using SAS software,
version 9.2.3 (SAS Institute Inc., Cary, NC).
4. Results
4.1. Demographics. Table 1 presents the demographic char-
acteristics of the 64 subjects who completed the study (24
males and 40 females). The mean age in years was 63.70
(SD = 14.00). Most of them (>90%) were cohabitating and
live at home. A total of 74 subjects approached the study
coordinator and requested participation in our APA study.
During the data collection, 3 decided to drop out due to no
eﬀects of APA, 2 were hospitalized during data collection, 2
felt too much pain on their ear, 2 had allergic reactions to the
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Figure 1: Auricular acupoints for low back pain treatment.
Figure 2: Acupoint finder.
Figure 3: Vaccaria seeds with tan colored tape.
tape, and 1 was out of town after participation in the study.
The retention rate was 87% (64/74). Patients who stayed in
the study were all able to adhere to the APA protocol at home
(at least 3 times/day, 3 minutes/time).
4.2. Pain Intensity and Pain Interference Change. Table 2
shows pain intensity and interference change from baseline
to day 7 (completion of the APA treatment). For the subjects
as a whole, the BPI worst pain score had decreased from
baseline (mean = 7.61, SD = 1.63) to day 1 (the first day of
the APA treatment) (mean 4.60, SD = 2.81, a reduction of
40%) and maintained about the same degree of worst pain
score at day 1 over the course of APA (mean ranged from 3.54
to 4.59). The percentage decrease at day 6 reached 54% and
was the only day with over 50% percentage decrease while
receiving auricular acupressure. Averaged pain and overall
pain severity had similar change patterns of worst pain and
had over 55% pain reduction by the end of the 7-day APA
treatment. The mean score of pain interference was 4.63
(SD = .31) and had reached the highest decrease at day 6
(mean = 1.6, a reduction of 64%).
4.3. Minimum Clinical Important Diﬀerences (MCIDs).
According to the “Pain Improvement” questionnaire, 36
subjects rated themselves as “improved,” whereas 22 subjects
rated themselves as “stable.” Table 3 lists the MCIDS for
worst pain, average pain, and pain intensity at baseline
and by the end of APA treatment (end point) for both
“Improved” and “Stable” groups. The change patterns for
pain score change and pain interferences for 8 data point
times are shown in Figure 4. The MCIDs using the Patient
Satisfaction score as the anchor were an improvement of
−1.86 points for BPI worst pain, −0.84 for BPI average
pain, −1.16 for BPI severity, and −0.70 for BPI interference.
The MCIDs expressed as percentage of improvement from
baseline were 24.9% for the BPI worst pain score, 12.3% for
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Table 1: Demographic characteristics of the subjects.
N (%)





















Mean pain intensity score at baseline Mean (standard deviation)
Worst pain 7.62 (1.62)
Average pain 6.63 (1.93)
Pain severity 6.27 (1.84)
Pain interference 4.88 (2.75)
BPI average pain score, 19.0% for the BPI pain severity, and
14.5% for BPI pain interference.
4.4. Patient Satisfaction. Fifty-five subjects (86%) reported
fewer episodes of pain and improved pain (Table 4). Sixty-
nine percent of patients took less pain medication than
before treatment; 62% subjects felt “much better” after the
APA treatment. The mean improvement percentage of pain
after APA was 57.02 (SD = 25.23). Only one patient reported
feeling worse. Only 8% subjects were not satisfied with the
APA.
5. Discussion
Our study showed that subjects with CLBP reported a 46%
reduction in BPI worst pain, 54% reduction in BPI average
pain, 56% reduction in BPI pain severity, and 55% reduction
in BPI pain interference after 7 days of APA. By the end
of the study, 62.5% of subjects also reported less pain
medication use during the APA treatment. The retention
rate for this study was 87% for the 7-day intervention of
APA. The MCIDs for BPI worst pain, BPI average pain, BPI
pain severity, and BPI pain inferences ranged from .70 to
1.86 points. The percentage improvement of MCIDs from
baseline was 14.5–24.9%.
Before interpretation of the study findings, several study
limitations must be acknowledged. First, the subjects in
this study approached the study coordinators to request
participation in the study. Thus the high retention rates
cannot be extrapolated to the general population, who may
not be interested in complementary and alternative medicine
(CAM). Second, our study did not have a placebo-control
group, so we are not able to diﬀerentiate the true eﬀects of
APA from the possible psychological eﬀects of the patients’
expectation of APA treatment and daily phone calls by the
data collectors. We did not investigate the causes of CLBP,
and the follow-up period was short in this study, limiting the
conclusions that can be drawn. Another limitation of this
feasibility study was that the subjects were derived from a
convenience sample of individuals who accompanied cancer
subjects to a cancer study center study site for APA, and
these individuals requested that we let them try APA for
their CLBP. We did not collect data from CLBP center and
thus did not have access to an expert in CLBP as part of
our team. We were very surprised at the number of people
who came forward wanting to try APA for CLBP, and we
did not know if it would help them. In a future clinical trial
on subjects with CLBP, we would include at least one CLBP
expert on our team. In addition, a CLBP-related dysfunction
measure, namely, Roland-Morris Disability Questionnaire
(RMDQ) [38, 39] would be used to assess the impact of daily
functioning (back-related).
During the APA treatment, two patients dropped out of
the study due to their allergy to the tapes. The tape we used
for APA treatment contained latex (provided by Auricular
Medicine International Research & Training Center, Florida,
US). A latex-free, hypoallergenic, and gentle tape will be used
in any future study to reduce skin irritation. Approximately
2/3 patients reported pain on their ears when they pressed
the tapes in the first couple of days and the pain sensation
on their ear decreased gradually. This pain sensation on the
ear is much higher than the previous study using auricular
acupuncture, in which the needle stayed in situ for 48 hours
(14%) [20]. Most subjects in our study indicated that they
were comfortable with the therapy after a couple of days and
expressed their willingness to endure the ear pain as long as
their CLBP could be relieved, although two subjects (3%)
decided to drop out due to the sharp pain in their ear when
they pressed the tapes. Thus, it is important to advise the
subjects about the potential side eﬀect of pain when they
receive APA treatment. During the study period, a trained
data collector called the subjects daily to query their APA
practice and their pain intensity. All of the subjects followed
the APA instructions. Over 90% subjects also indicated that
they followed the frequency, duration, and time for the APA
practice at home.
The pain intensity change (BPI worst pain, average pain,
and pain severity) by the end of the 7-day APA treatments is
lower in over 47% in subjects when compared with baseline,
which is higher than that reported in auricular acupuncture
studies of CLBP [14, 18, 20]. In a combination auricular
acupuncture and exercise 12-week intervention program,
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Table 2: The trend of mean pain score and interference from baseline to day 7 and the diﬀerence of mean pain score between each treatment
day and baseline.
Worst pain Average pain Severity Interference
Mean (SD) Change (%) Mean (SD) Change (%) Mean (SD) Change (%) Mean (SD) Change (%)
D0 7.61 (1.63) 6.33 (1.94) 6.29 (1.85) 4.88 (2.77)
D1 4.60 (2.81) 3.42 (2.42) 3.41 (2.39) 2.70 (2.78)
D2 4.59 (2.87) 3.24 (2.70) 3.25 (2.44) 2.66 (2.86)
D3 4.06 (2.99) 2.77 (2.66) 2.79 (2.42) 2.27 (2.64)
D4 4.42 (2.87) 2.92 (2.48) 3.01 (2.38) 2.23 (2.58)
D5 4.14 (2.85) 2.86 (2.48) 2.94 (2.35) 1.89 (2.52)
D6 3.54 (2.71) 2.30 (2.16) 2.49 (2.15) 1.89 (2.48)
D7 4.13 (3.15) 2.89 (2.72) 2.96 (2.57) 2.31 (2.65)
D1 versus D0 −3.01 (2.27) −39.57% −2.91 (2.18) −46.01% −2.88 (2.12) −45.79% −2.18 (2.18) −44.61%
D2 versus D0 −3.03 (2.29) −39.75% −3.09 (2.33) −48.78% −3.04 (2.14) −48.38% −2.22 (2.22) −45.52%
D3 versus D0 −3.56 (2.33) −46.71% −3.55 (2.28) −56.17% −3.50 (2.12) −55.66% −2.61 (2.61) −53.41%
D4 versus D0 −3.19 (2.25) −41.95% −3.41 (2.19) −53.86% −3.28 (2.09) −52.13% −2.65 (2.65) −54.24%
D5 versus D0 −3.47 (2.23) −45.57% −3.47 (2.19) −54.85% −3.34 (2.08) −53.18% −2.99 (2.99) −61.25%
D6 versus D0 −4.07 (2.16) −53.49% −4.03 (2.04) −63.66% −3.80 (1.98) −60.48% −2.99 (2.99) −61.26%
D7 versus D0 −3.48 (2.42) −45.72% −3.44 (2.32) −54.38% −3.33 (2.20) −52.89% −2.57 (2.57) −52.69%
D: day, SD: standard deviation.
Table 3: Estimation of mean changes in BPI average pain and BPI severity scores∗.
Subject numbers Baseline End point Mean change
Pain Score Anchor status† Mean (SD) Mean (SD) Mean (SD) Mean (SD) MCIDs‡
Worst pain
Improved 36 7.47 (1.70) 3.32 (2.96) −4.15 (2.37) −1.86 (45.72)
Stable 22 7.76 (1.67) 5.47 (3.12) −2.29 (2.42)
Average pain
Improved 36 6.03 (1.84) 2.25 (2.52) −3.78 (2.18) −0.74 (54.38)
Stable 22 6.57 (2.04) 3.53 (2.53) −3.04 (2.27)
Severity
Improved 36 6.09 (1.94) 2.27 (2.18) −3.83 (2.05) −1.16 (52.88)
Stable 22 6.45 (1.86) 3.78 (2.59) −2.67 (2.22)
Interference
Improved 36 4.82 (2.69) 2.02 (2.50) −2.80 (2.60) −0.70 (52.69)
Stable 22 4.65 (2.94) 2.55 (2.84) −2.10 (2.90)
MCIDs: minimum clinically important diﬀerences.
†Grouped according to responses from treatment satisfaction questionnaire.
‡Expressed as score reduction (Improved, Stable) and percent reduction from baseline.
subjects with CLBP showed mean improvement of pain
intensity (−0.93 point at by the end of intervention and
−2.08 at 6 month follow up) [20]. The comparison of 1-week
of pain intensity change was not available since data was not
shown for this study. The greater improvement of our study
after 1-week APA shows the potential benefit to reduce CLBP.
Further studies are needed to validate the analgesic eﬀects of
APA treatment for longer duration following the treatment.
The MCIDs (mean ranged from 0.74 from 1.86 and
12–25% change) calculated in this study were lower than
other previous studies, which had approximately a 2-point
improvement (35–55% improvement) [27, 40]. These esti-
mates are greater than our study findings. These diﬀerences
may be due to the diﬀerent patients studied, pain types,
and study design. In our study, we assessed only a 1-week
APA treatment, without control/placebo groups. We used
patients’ rated improvement on a scale of a 5-category
assessment and previous studies used scale of 7-category
ordinal assessment as the anchor for the BPI. Therefore, our
study had a lower response profile.
APA is an extremely aﬀordable therapy to practice and
research. One tape with seeds costs about $0.12 and every
APA treatment may cost from $1.2 to $2.4, depending on
how many tapes were used. The most significant advantage
of APA is that once the tapes are placed by a trained
practitioner, the patients can press the acupoints at home
by themselves. In contrast, subjects who receive acupuncture
treatment need to visit the therapist’s oﬃce to receive the
treatment administered by the registered acupuncturist. The
number and frequency of acupuncture treatments vary, but
a minimum of 12 sessions of acupuncture is suggested for
CLBP to get the most benefits (2 sessions per week for 4
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Figure 4: Change patterns of worst pain, average pain, pain severity, and pain interference from baseline to day 7 between subjects who were
self-rated “Improved” and “Stable” groups.
weeks and then 1 session per week for 4 weeks) [10]. The
cost of acupuncture treatment varies and may range from
$65 to $125 per session [41]. Medicare and Medicaid do not
cover acupuncture; however, the proportion of third-party
plans providing coverage is increasing [42]. In addition,
acupuncture treatment for CLBP is not necessarily lower
in cost. Studies have shown no cost savings in back care
services after 1 year among groups receiving acupuncture
compared with patients who received massage or self-care
[43] or have shown a modest increase in overall treatment
costs [44, 45] when in adjunct to usual care. Although
auricular acupuncture, which can leave the needle in situ
for up to 1 month, may solve the problems of frequent
therapist oﬃce visits [18, 46], it must be administered by
a licensed therapist. If APA can achieve treatment eﬀects
comparable to acupuncture, the use of APA will receive far
more application in clinical settings. The tapes may be able to
stay on subject’s ear longer—up to two to three weeks—if the
subjects do not have allergic reactions to the tape. APA can be
administered by a broader range of health care professionals
because APA does not require insertion of needles. Health
care professionals such as nurses, physical therapists, and
psychologists can be taught through continuing education,
and then be able to incorporate APA into clinical practice.
Consistent with previous studies [14], subjects in the
current study decreased the use of pain medication during
the APA treatment. All of the subjects indicated their desire
to reduce pain medication when they enrolled in the study.
In addition to the cost saving in medication use, the
reduction of pain medication used (such as nonsteroidal
anti-inflammatory drugs and opioids) can also decrease the
risk of potential side eﬀects (i.e., gastrointestinal bleeding,
nausea, vomiting, constipation, and dizziness [47, 48]).
In this study, we tested only a 7-day APA treatment.
The eﬀects of APA reached the maximal pain reduction on
Day 4 and decreased after Day 5. Dr. Huang has suggested
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Much better 40 (62)
Better 24 (15)
About the same 13 (8)
Worse 1 (1)
How much better mean (SD) 57.02 (25.23)
Satisfaction about the progress
Completely 45 (71)
Somewhat 14 (21)
Not satisfied 5 (8)
that a course of APA treatment should include a cycle of 4
treatments (5-day continuous treatment with 2 days oﬀ and
repeated for 4 weeks) [11]. This treatment duration is similar
to suggested acupuncture treatment [10]. Further studies are
needed to determine the optimal duration of treatment to
achieve sustained therapeutic eﬀects.
In order to examine the true eﬀects of APA, a large-
scale randomized clinical trial would be required, including a
sham group, tracking of long-term eﬀects, and examination
of a longer treatment duration (i.e., 4-week or 6-week [18])
to obtain the maximum eﬀects. In addition, understanding
the underlying biological mechanisms associated with APA
may explain how the neuroendocrine, immunologic, and
other physiological processes are related to auricular acupres-
sure analgesia.
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